Lupin

Pharma Courses  
  • Lupin looking for Regulatory Affairs Executive
    10 September 2025

    Lupin looking for Regulatory Affairs Executive

    Responsible for post approval submissions to Europe, Australia, New Zealand and Canada market. To provide Regulatory inputs during inspections by Regulatory authorities and Customer as and when required. 
  • 4 September 2025
    Virtual Interview for B.Pharm, MSc in Quality Control at Lupin
    Analysis of formulation and stability samples tablets dosage, (in-process/ /BU/cu/Assay/Dissolution/RS/ovi) RM/FP/SS, OOS and OOT handling and report writing, Handling of laboratory deviation.
  • 29 November 2024
    Lupin Limited Walk in drive at Ahmedabad for B.Pharm, MSc in QC Department
    Analyst worked in AMT, AMV section having exposure to HPLC, GC, IC, AAS. Analyst worked in GLP Section having exposure instrument calibration, Qualification, Standard Management, Working Standard qualification.
  • 30 August 2024
    Walk In Drive for B.Pharm, MSc, BSc in Quality Control at LUPIN Ltd
    Experiences in HPLC, GC, LCMS, GCMS, IR, UV, Dissolution, Polarimeter, Potentiometric titrations, KF, PSD by Malvern and Other wet & Physical analysis
  • 16 July 2024
    Lupin Walk in Drive for B.Pharm, MSc in Quality Control
    Should be from any reputed pharma plant only having regulatory exposure like US-FDA, MHRA, etc.
  • 27 December 2023
    Job for B.Pharm, MSc, BSc in QA, QC at Lupin Limited

    Lupin Limited is one of India's largest manufacturers of bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.

  • 4 September 2023
    Walk in for B.Pharm, MSc, BSc in Production, QA, QC at Lupin Limited

    Lupin Limited is one of India's largest manufacturers of bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.

Subscribe to Lupin